Tractor maker Kukje Machinery receives bids from two companies Final round of bidding expected in mid-June
Translated by Ryu Ho-joung 공개 2021-05-27 08:30:37
이 기사는 2021년 05월 27일 07:36 thebell 에 표출된 기사입니다.
South Korea’s tractor maker Kukje Machinery received preliminary offers from two strategic investors, with the final bidding expected to take place in mid-June, industry sources said.Some financial investors that initially showed interest in the company pulled out, reducing competition among bidders. The price tag for the company is estimated to be between 60 billion won and 70 billion won ($63 million).
United Asset Management Company (UAMCO) and Keystone Private Equity, which together hold a majority stake in the company, gave the bidders access to the virtual data room to start the due diligence process. They are expected to receive final offers as early as the middle of next month.
Kukje Machinery holds the fourth largest share in the domestic agricultural machinery market. It was offloaded by Dongkuk Steel in 2016 as part of restructuring efforts by the steel maker. A consortium consisting of UAMCO, Keystone Private Equity and rival tractor maker TYM Corp bought the company for 58 billion won.
The company has continued to grow in the past four years. Its revenue rose from 198.4 billion won in 2016 to 290 billion won in 2020. Operating income quadrupled to 10 billion won in the same period.
TYM had a call option that gives the company a right to buy shares in Kukje Machinery from the other two investors. But TYM decided not to exercise it in August last year, leading them to embark on the sale process.
Kukje Machinery’s strong growth in overseas markets is likely to attract potential buyers. The company’s revenue generated from North America has grown at an annual rate of 30% in recent years. The company also benefited from the pandemic-induced demand, with its first-quarter revenue rising 50% year-on-year. (Reporting by Se-hun Jo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [IPO 모니터]약국 플랫폼 바로팜, 대표 주관사 '미래에셋' 선정
- [Market Watch]증권채 투심 개선...A급 증권사는 여전히 '신중모드'
- [제일약품의 온코닉테라퓨틱 첫 '신약']세번째 P-CAB '자큐보' 2년만에 신약 명맥 잇는다
- 강동그룹, 디아너스CC 품는다
- [제약사 TSR 분석]제일약품, '주가·실적·배당' 3중고 열쇠 '온코닉의 신약'
- (여자)아이들 우기, 'YUQ1' 아이튠즈 앨범차트 10개국 석권
- 박셀바이오, 진행성 간세포암 타깃 'Vax-NK' 특허 출원
- 베니스 비엔날레, 30년만에 두발로 선 '곽훈'의 의미
- [대기업 프로스포츠 전술전략]'모기업발 숙제' 엔씨다이노스, 당분간 긴축 불가피
- 하이브, '민희진 없는' 어도어 경쟁력 입증할까